Popular prescription weight loss drugs linked to uncommon blindness condition

A study led by investigators from Mass Eye and Ear found that patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye condition called NAION (non-arteritic anterior ischemic optic neuropathy) than similar patients who had not been prescribed these drugs.

​Medical Xpress – latest medical and health news stories

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *